Shares in Novo Nordisk were up nearly 12% today – hiking its valuation to more than $280 billion – after it reported new clinical data with one of its obesity drug candidates. The new results ...
Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs. The latest attempt focuses ...
Han har blandt andet taget et kig på medicinalgiganten Novo Nordisk, hvis regnskab han har givet karakteren 10. Det er den højeste karakter, han har uddelt i denne regnskabssæson. Udover Novo Nordisk ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
After hours: March 21 at 7:59:39 PM EDT ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
After hours: 19 March at 19:58:57 GMT-4 Loading Chart for NVO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback